so what is next ??It seems to me that AGN chose not to go Phase 3 trial, not that FDA ruled against Ifenprodil, and the most outstanding reason to me is the projected trial size, costs and timellines needed. I am curious now that the company may be weighing their decision against better outcomes in another trial. maybe IPF? From what I have read and heard, Ifenprodil definitely has a positive results on the lungs. The company is pretty quiet about those lung e-rays. Not to mention the intriguing pancreatic cancer research and Ifenprodil effectiveness against tumors. I am going to stick around, not dumping yet because I also really want to see the DMT trials playout.